2'-Deoxycytidine-13C9,15N3
CAT:
804-HY-D0184S3-01
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

2'-Deoxycytidine-13C9,15N3
- CAS Number: 1987883-22-6
- UNSPSC Description: 2'-Deoxycytidine-13C9,15N3 (Deoxycytidine-13C9,15N3; Cytosine deoxyriboside-13C9,15N3; Deoxyribose cytidine-13C9,15N3) is 13C and 15N-labeled 2'-Deoxycytidine (HY-D0184). 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu).
- Target Antigen: Endogenous Metabolite; Isotope-Labeled Compounds
- Type: Isotope-Labeled Compounds
- Related Pathways: Metabolic Enzyme/Protease;Others
- Field of Research: Others
- Assay Protocol: https://www.medchemexpress.com/2-deoxycytidine-13c9-15n3.html
- Purity: 99.00
- Solubility: 10 mM in DMSO
- Smiles: O=[13C]1[15N]([13C@H]2[13CH]([H])[13CH](O)[13C@@H]([13CH2]O)O2)[13CH]=[13CH][13C]([15NH2])=[15N]1
- Molecular Weight: 239.13
- References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Horn D, et al. Inhibition of biological effects of bromodeoxyuridine by deoxycytidine: correlation with decreased incorporation of bromodeoxyuridine into DNA. Somatic Cell Genet. 1976 Sep;2(5):469-81.
- Shipping Conditions: Blue Ice
- Storage Conditions: Solution, -20°C, 2 years
- Clinical Information: No Development Reported